Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation

被引:106
作者
Holloway, Julianne L. [1 ]
Ma, Henry [1 ]
Rai, Reena [1 ]
Burdick, Jason A. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
Hydrogel; Hyaluronic acid; Bone repair; Bone morphogenetic protein; Calvarial defect; HYALURONIC-ACID HYDROGELS; MATRIX METALLOPROTEINASES; TISSUE REGENERATION; CALVARIAL DEFECT; DRUG-DELIVERY; SCAFFOLDS; BMP-2; BIOMATERIALS; RETENTION; RELEASE;
D O I
10.1016/j.jconrel.2014.05.053
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties of MaHA hydrogels were characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.%) or maleimide functionalization (10-40%f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulations with distinct BMP-2 release profiles were evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observed within defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 47 条
  • [1] Andreu D, 1994, Methods Mol Biol, V35, P91
  • [2] Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix
    Ben-David, Dror
    Srouji, Samer
    Shapira-Schweitzer, Keren
    Kossover, Olga
    Ivanir, Eran
    Kuhn, Gisela
    Mueller, Ralph
    Seliktar, Dror
    Livne, Erella
    [J]. BIOMATERIALS, 2013, 34 (12) : 2902 - 2910
  • [3] Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)
    Bessa, P. C.
    Casal, M.
    Reis, R. L.
    [J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2008, 2 (2-3) : 81 - 96
  • [4] A MODIFIED URONIC ACID CARBAZOLE REACTION
    BITTER, T
    MUIR, HM
    [J]. ANALYTICAL BIOCHEMISTRY, 1962, 4 (04) : 330 - &
  • [5] Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies
    Boden, SD
    Kang, J
    Sandhu, H
    Heller, JG
    [J]. SPINE, 2002, 27 (23) : 2662 - 2673
  • [6] Hyaluronic Acid Hydrogels for Biomedical Applications
    Burdick, Jason A.
    Prestwich, Glenn D.
    [J]. ADVANCED MATERIALS, 2011, 23 (12) : H41 - H56
  • [7] Biomaterial developments for bone tissue engineering
    Burg, KJL
    Porter, S
    Kellam, JF
    [J]. BIOMATERIALS, 2000, 21 (23) : 2347 - 2359
  • [8] A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned
    Carragee, Eugene J.
    Hurwitz, Eric L.
    Weiner, Bradley K.
    [J]. SPINE JOURNAL, 2011, 11 (06) : 471 - 491
  • [9] Cooper GM, 2010, TISSUE ENG PT A, V16, P1749, DOI [10.1089/ten.tea.2009.0650, 10.1089/ten.TEA.2009.0650]
  • [10] Hydrogels for tissue engineering: scaffold design variables and applications
    Drury, JL
    Mooney, DJ
    [J]. BIOMATERIALS, 2003, 24 (24) : 4337 - 4351